0000950170-24-038102.txt : 20240328
0000950170-24-038102.hdr.sgml : 20240328
20240328163239
ACCESSION NUMBER: 0000950170-24-038102
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240326
FILED AS OF DATE: 20240328
DATE AS OF CHANGE: 20240328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dupont Jakob
CENTRAL INDEX KEY: 0001553335
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40881
FILM NUMBER: 24799651
MAIL ADDRESS:
STREET 1: C/O ONCOMED PHARMACEUTICALS, INC.
STREET 2: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pyxis Oncology, Inc.
CENTRAL INDEX KEY: 0001782223
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831160910
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 HARRISON AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02118
BUSINESS PHONE: (617) 221-9059
MAIL ADDRESS:
STREET 1: 321 HARRISON AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02118
4
1
ownership.xml
4
X0508
4
2024-03-26
false
0001782223
Pyxis Oncology, Inc.
PYXS
0001553335
Dupont Jakob
C/O PYXIS ONCOLOGY, INC.
321 HARRISON AVENUE, 11TH FL. SUITE 1
BOSTON
MA
02118
true
false
false
false
false
Common Stock
2024-03-26
4
A
false
38741
0
A
38741
D
Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.
/s/ Pamela Connealy, Attorney-in-Fact for Jakob Dupont
2024-03-28